hVIVO plc (LON:HVO) Insider Yamin Mo’ Khan Sells 3,062,246 Shares

hVIVO plc (LON:HVO) insider Yamin Mo’ Khan sold 3,062,246 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of GBX 17 ($0.22), for a total transaction of £520,581.82 ($672,847.12).

hVIVO Price Performance

Shares of hVIVO stock opened at GBX 17.25 ($0.22) on Friday. The company has a debt-to-equity ratio of 33.86, a current ratio of 1.61 and a quick ratio of 1.16. The stock has a market capitalization of £122.06 million, a P/E ratio of 7.11 and a beta of 0.97. hVIVO plc has a one year low of GBX 15.50 ($0.20) and a one year high of GBX 32 ($0.41). The business’s 50 day simple moving average is GBX 18.26 and its two-hundred day simple moving average is GBX 23.44.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.